Core Viewpoint - Rosen Law Firm is encouraging investors of Avantor, Inc. to secure legal counsel before the December 29, 2025 deadline for a class action lawsuit related to the company's stock performance during the specified class period [2][3]. Group 1: Class Action Details - The class period for the Avantor, Inc. stock is defined as March 5, 2024, to October 28, 2025, inclusive [2]. - Investors who purchased Avantor common stock during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. Group 2: Legal Representation - Investors are advised to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [5]. - Rosen Law Firm has a history of significant settlements, including the largest securities class action settlement against a Chinese company, and has consistently ranked highly in terms of settlements achieved [5]. Group 3: Allegations Against Avantor - The lawsuit alleges that Avantor misrepresented its competitive positioning and failed to disclose negative impacts from increased competition, leading to materially false and misleading statements about its business and prospects [6].

NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Perrigo Company plc (NYSE: PRGO) between February 27, 2023 and November 4, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 16, 2026. SO WHAT: If you purchased Perrigo securities during the Class Period y ...

ROSEN, A LONGSTANDING LAW FIRM, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - MLTXNovember 24, 2025 4:55 PM EST | Source: The Rosen Law Firm PANew York, New York--(Newsfile Corp. - November 24, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, both dates inclusive (the "Class Per ...

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSPNovember 24, 2025 4:20 PM EST | Source: The Rosen Law Firm PANew York, New York--(Newsfile Corp. - November 24, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the "Class Per ...

Core Viewpoint - Rosen Law Firm is encouraging investors of WPP plc who incurred losses exceeding $100,000 during the specified class period to secure legal counsel before the December 8, 2025 deadline for lead plaintiff applications in a securities class action lawsuit [1][2]. Group 1: Class Action Details - The class period for the WPP ADSs is from February 27, 2025, to July 8, 2025, inclusive [1]. - Investors who purchased WPP ADSs during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must act by December 8, 2025, to serve as lead plaintiff [3]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting that many firms issuing notices may lack the necessary experience and resources [4]. - The firm has a history of significant recoveries for investors, including over $438 million in 2019 alone, and has been recognized as a leader in securities class action settlements [4]. Group 3: Allegations Against WPP - The complaint alleges that WPP's management provided overly positive statements while concealing material adverse facts about the company's media arm, which was reportedly unprepared for macroeconomic challenges and losing market share [5].

Core Viewpoint - Rosen Law Firm is encouraging investors of Marex Group plc who incurred losses exceeding $100,000 during the specified class period to seek legal counsel before the December 8, 2025 deadline for lead plaintiff applications [1]. Group 1: Legal Action Details - Investors who purchased Marex securities between May 16, 2024, and August 5, 2025, may be eligible for compensation without upfront costs through a contingency fee arrangement [2]. - To participate in the class action, investors can visit the provided link or contact the law firm directly for more information [3][6]. - The lawsuit alleges that Marex made materially false statements and failed to disclose critical information regarding its financial practices, leading to investor damages when the truth was revealed [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest against a Chinese company [4]. - The firm has been recognized for its success in securities class action settlements, ranking No. 1 in 2017 and consistently in the top 4 since 2013, recovering hundreds of millions for investors [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in handling such cases [4].

Core Viewpoint - Rosen Law Firm is encouraging investors of Cepton, Inc. who experienced losses exceeding $100,000 during the specified Class Period to seek legal counsel before the December 8, 2025 deadline for lead plaintiff applications [1][2]. Group 1: Class Action Details - The Class Period for the Cepton, Inc. securities class action is from July 29, 2024, to January 6, 2025 [1]. - Investors who purchased or sold Cepton common stock during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Legal Representation - Investors are advised to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - Rosen Law Firm has a history of significant settlements, including the largest securities class action settlement against a Chinese company, and has recovered hundreds of millions of dollars for investors [4]. Group 3: Allegations Against Cepton - The lawsuit alleges that Cepton's management made materially false and misleading statements regarding the company's business and operations, particularly concerning a third-party bid that valued Cepton at more than double the Koito Acquisition [5]. - It is claimed that Cepton's Board of Directors failed to adequately explore this offer and did not disclose its terms, depriving shareholders of the opportunity to make an informed decision regarding the Koito Acquisition [5].

Core Viewpoint - Rosen Law Firm is encouraging investors of Telix Pharmaceuticals Ltd. to secure legal counsel before the January 9, 2026 deadline for a securities class action lawsuit related to the company's misleading statements during the class period from February 21, 2025 to August 28, 2025 [1][5]. Group 1: Legal Action Details - Investors who purchased Telix securities during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by January 9, 2026 [3]. - The lawsuit alleges that Telix made materially false and misleading statements regarding its prostate cancer therapeutic candidates and the quality of its supply chain, leading to investor damages when the truth was revealed [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been ranked No. 1 for securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions of dollars for investors [4]. - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a Titan of the Plaintiffs' Bar in 2020 [4].

Core Viewpoint - Rosen Law Firm is encouraging investors of MoonLake Immunotherapeutics to secure legal counsel before the December 15, 2025 deadline for a securities class action related to the company's stock performance during the specified class period [2][3]. Group 1: Class Action Details - Investors who purchased common stock of MoonLake between March 10, 2024, and September 29, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - The deadline to move the court to serve as lead plaintiff is December 15, 2025, with the lead plaintiff acting on behalf of other class members [4]. Group 2: Legal Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for the number of settlements in 2017 [5]. - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [5]. Group 3: Case Allegations - The complaint alleges that during the class period, defendants made false or misleading statements regarding the efficacy of their product SLK compared to traditional monoclonal antibodies, leading to investor damages when the truth was revealed [6].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of aTyr Pharma, Inc. during the specified class period of the upcoming lead plaintiff deadline on December 8, 2025, for a class action lawsuit related to misleading statements about the drug Efzofitimod [1][5]. Group 1: Class Action Details - Investors who bought aTyr Pharma common stock between January 16, 2025, and September 12, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To participate in the class action, investors can visit the provided link or contact the law firm for more information [3][6]. - A lead plaintiff must file a motion with the court by December 8, 2025, to represent other class members in the litigation [3]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been consistently ranked among the top firms for securities class action settlements, recovering hundreds of millions of dollars for investors, with over $438 million secured in 2019 alone [4]. - Founding partner Laurence Rosen has been recognized as a leading figure in the plaintiffs' bar, highlighting the firm's expertise and reputation in handling such cases [4]. Group 3: Case Allegations - The complaint alleges that aTyr Pharma provided misleading statements regarding the efficacy of Efzofitimod, particularly concerning its ability to allow patients to taper off steroid usage completely [5]. - The lawsuit claims that when the true information became public, investors suffered damages due to the misleading nature of the statements made by the company [5].